Cargando…

Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD

INTRODUCTION: The purpose of this study was to investigate the feasibility and superiority of using the WeChat platform for midterm clinical follow-up of children who underwent transthoracic device closure for ventricular septal defects (VSDs). METHODS: Ninety children with VSDs who underwent transt...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wen-Peng, Liu, Jian-Feng, Lei, Yu-Qing, Wang, Zeng-Chun, Chen, Qiang, Cao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cirurgia Cardiovascular 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054152/
https://www.ncbi.nlm.nih.gov/pubmed/33656834
http://dx.doi.org/10.21470/1678-9741-2020-0376
_version_ 1784697132477841408
author Xie, Wen-Peng
Liu, Jian-Feng
Lei, Yu-Qing
Wang, Zeng-Chun
Chen, Qiang
Cao, Hua
author_facet Xie, Wen-Peng
Liu, Jian-Feng
Lei, Yu-Qing
Wang, Zeng-Chun
Chen, Qiang
Cao, Hua
author_sort Xie, Wen-Peng
collection PubMed
description INTRODUCTION: The purpose of this study was to investigate the feasibility and superiority of using the WeChat platform for midterm clinical follow-up of children who underwent transthoracic device closure for ventricular septal defects (VSDs). METHODS: Ninety children with VSDs who underwent transthoracic device closure were divided into a WeChat follow-up group (WFU group) and an outpatient follow-up group (OFU group). The patients were followed up via WeChat or at an outpatient clinic three months and one year after discharge. The incidences of adverse events, associated complications, costs and time spent, loss to follow-up rate, medication adherence, and overall satisfaction were recorded. RESULTS: There was no statistically significant difference in the incidence of adverse events or postoperative complications between the two groups. Also, the loss to follow-up rate was similar between them. Compared with the OFU group, there were significant statistical advantages in the WFU group regarding the total time and cost spent, medication adherence, and satisfaction. CONCLUSION: The use of the WeChat platform in midterm clinical follow-up of children who underwent transthoracic device closure for VSDs has the advantages of reducing financial and time burdens, facilitating high medication adherence, and leading to high satisfaction.
format Online
Article
Text
id pubmed-9054152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Cirurgia Cardiovascular
record_format MEDLINE/PubMed
spelling pubmed-90541522022-05-02 Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD Xie, Wen-Peng Liu, Jian-Feng Lei, Yu-Qing Wang, Zeng-Chun Chen, Qiang Cao, Hua Braz J Cardiovasc Surg Original Article INTRODUCTION: The purpose of this study was to investigate the feasibility and superiority of using the WeChat platform for midterm clinical follow-up of children who underwent transthoracic device closure for ventricular septal defects (VSDs). METHODS: Ninety children with VSDs who underwent transthoracic device closure were divided into a WeChat follow-up group (WFU group) and an outpatient follow-up group (OFU group). The patients were followed up via WeChat or at an outpatient clinic three months and one year after discharge. The incidences of adverse events, associated complications, costs and time spent, loss to follow-up rate, medication adherence, and overall satisfaction were recorded. RESULTS: There was no statistically significant difference in the incidence of adverse events or postoperative complications between the two groups. Also, the loss to follow-up rate was similar between them. Compared with the OFU group, there were significant statistical advantages in the WFU group regarding the total time and cost spent, medication adherence, and satisfaction. CONCLUSION: The use of the WeChat platform in midterm clinical follow-up of children who underwent transthoracic device closure for VSDs has the advantages of reducing financial and time burdens, facilitating high medication adherence, and leading to high satisfaction. Sociedade Brasileira de Cirurgia Cardiovascular 2022 /pmc/articles/PMC9054152/ /pubmed/33656834 http://dx.doi.org/10.21470/1678-9741-2020-0376 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Xie, Wen-Peng
Liu, Jian-Feng
Lei, Yu-Qing
Wang, Zeng-Chun
Chen, Qiang
Cao, Hua
Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD
title Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD
title_full Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD
title_fullStr Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD
title_full_unstemmed Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD
title_short Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD
title_sort application of wechat platform in midterm clinical follow-up of children who underwent transthoracic device closure of vsd
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054152/
https://www.ncbi.nlm.nih.gov/pubmed/33656834
http://dx.doi.org/10.21470/1678-9741-2020-0376
work_keys_str_mv AT xiewenpeng applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd
AT liujianfeng applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd
AT leiyuqing applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd
AT wangzengchun applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd
AT chenqiang applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd
AT caohua applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd